Advertisement

Index by Author

May 1980; 29 (5)
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

A

  1. Arquilla, E R

    • Induction of hyperglycemia with insulin antibodies to B-chain determinants. Diabetes May 1980 29:383-390; doi:10.2337/diabetes.29.5.383

B

  1. Boden, G

    • Effects of therapy on the nature and quantity of fuels oxidized during diabetic ketoacidosis. Diabetes May 1980 29:365-372

  2. Brodows, R G

    • Effects of indomethacin on acute insulin release in man. Diabetes May 1980 29:379-382; doi:10.2337/diabetes.29.5.379

C

  1. Czech, M P

    • Insulin action and the regulation of hexose transport. Diabetes May 1980 29:399-409

D

  1. Danney, M M

    • Integrated concentration of growth hormone in juvenile-onset diabetes. Diabetes May 1980 29:391-398; doi:10.2337/diabetes.29.5.391

G

  1. Graf, R

    • Potentiation of insulin secretion to nonglucose stimuli in normal man by tolbutamide. Diabetes May 1980 29:335-340; doi:10.2337/diabetes.29.5.335

H

  1. Halter, J B

    • Potentiation of insulin secretion to nonglucose stimuli in normal man by tolbutamide. Diabetes May 1980 29:335-340; doi:10.2337/diabetes.29.5.335

  2. Hayford, J T

    • Integrated concentration of growth hormone in juvenile-onset diabetes. Diabetes May 1980 29:391-398; doi:10.2337/diabetes.29.5.391

  3. Hendrix, J A

    • Integrated concentration of growth hormone in juvenile-onset diabetes. Diabetes May 1980 29:391-398; doi:10.2337/diabetes.29.5.391

  4. Hermansen, K

    • Duodenal contribution to pancreaticoduodenal vein islet hormones during stimulation of the canine pancreas with calcium. Diabetes May 1980 29:361-364; doi:10.2337/diabetes.29.5.361

I

  1. Issekutz, B, Jr

    • Clearance rates of metabolizable and nonmetabolizable sugars in insulin-infused dogs and in exercising dogs. Diabetes May 1980 29:348-354

J

  1. Jarett, L

    • A comparison of basal and insulin-stimulated glucose transport in rat adipocyte plasma membranes. Diabetes May 1980 29:373-378; doi:10.2337/diabetes.29.5.373

K

  1. Karakash, C

    • Effects of intraportal islet transplantation on the transplanted tissue and the recipient pancreas. I. Functional studies. Diabetes May 1980 29:341-347; doi:10.2337/diabetes.29.5.341

  2. Kelso, J M

    • Induction of hyperglycemia with insulin antibodies to B-chain determinants. Diabetes May 1980 29:383-390; doi:10.2337/diabetes.29.5.383

  3. Kennedy, A L

    • Nonenzymatically glycosylated serum protein: spurious elevation due to free glucose in serum. Diabetes May 1980 29:413-415; doi:10.2337/diabetes.29.5.413

  4. Kondo, M

    • Effect of adrenergic agents on the secretion of gastrointestinal immunoreactive glucagon in depancreatized dogs. Diabetes May 1980 29:355-360; doi:10.2337/diabetes.29.5.355

L

  1. Ludvigsen, C

    • A comparison of basal and insulin-stimulated glucose transport in rat adipocyte plasma membranes. Diabetes May 1980 29:373-378; doi:10.2337/diabetes.29.5.373

M

  1. Malaisse-Lagae, F

    • Effects of intraportal islet transplantation on the transplanted tissue and the recipient pancreas. I. Functional studies. Diabetes May 1980 29:341-347; doi:10.2337/diabetes.29.5.341

  2. Matschinsky, F M

    • Pirogliride: an oral hypoglycemic drug which accelerates glucose usage and insulin secretion by islets of Langerhans. Diabetes May 1980 29:410-412; doi:10.2337/diabetes.29.5.410

  3. Mehl, T D

    • Nonenzymatically glycosylated serum protein: spurious elevation due to free glucose in serum. Diabetes May 1980 29:413-415; doi:10.2337/diabetes.29.5.413

  4. Merimee, T J

    • Nonenzymatically glycosylated serum protein: spurious elevation due to free glucose in serum. Diabetes May 1980 29:413-415; doi:10.2337/diabetes.29.5.413

  5. Mozzoli, M A

    • Effects of therapy on the nature and quantity of fuels oxidized during diabetic ketoacidosis. Diabetes May 1980 29:365-372

O

  1. Orci, L

    • Effects of intraportal islet transplantation on the transplanted tissue and the recipient pancreas. I. Functional studies. Diabetes May 1980 29:341-347; doi:10.2337/diabetes.29.5.341

  2. Owen, O E

    • Effects of therapy on the nature and quantity of fuels oxidized during diabetic ketoacidosis. Diabetes May 1980 29:365-372

P

  1. Pfeifer, M A

    • Potentiation of insulin secretion to nonglucose stimuli in normal man by tolbutamide. Diabetes May 1980 29:335-340; doi:10.2337/diabetes.29.5.335

  2. Porte, D, Jr

    • Potentiation of insulin secretion to nonglucose stimuli in normal man by tolbutamide. Diabetes May 1980 29:335-340; doi:10.2337/diabetes.29.5.335

R

  1. Reichard, G A, Jr

    • Effects of therapy on the nature and quantity of fuels oxidized during diabetic ketoacidosis. Diabetes May 1980 29:365-372

  2. Renold, A E

    • Effects of intraportal islet transplantation on the transplanted tissue and the recipient pancreas. I. Functional studies. Diabetes May 1980 29:341-347; doi:10.2337/diabetes.29.5.341

  3. Roth, M D

    • Induction of hyperglycemia with insulin antibodies to B-chain determinants. Diabetes May 1980 29:383-390; doi:10.2337/diabetes.29.5.383

S

  1. Smith, R

    • Effects of therapy on the nature and quantity of fuels oxidized during diabetic ketoacidosis. Diabetes May 1980 29:365-372

T

  1. Tamai, I Y

    • Induction of hyperglycemia with insulin antibodies to B-chain determinants. Diabetes May 1980 29:383-390; doi:10.2337/diabetes.29.5.383

  2. Thompson, R G

    • Integrated concentration of growth hormone in juvenile-onset diabetes. Diabetes May 1980 29:391-398; doi:10.2337/diabetes.29.5.391

  3. Topol, E

    • Effects of indomethacin on acute insulin release in man. Diabetes May 1980 29:379-382; doi:10.2337/diabetes.29.5.379

  4. Trapp, V E

    • Effects of therapy on the nature and quantity of fuels oxidized during diabetic ketoacidosis. Diabetes May 1980 29:365-372

  5. Trimble, E R

    • Effects of intraportal islet transplantation on the transplanted tissue and the recipient pancreas. I. Functional studies. Diabetes May 1980 29:341-347; doi:10.2337/diabetes.29.5.341

V

  1. Valdes, I

    • Induction of hyperglycemia with insulin antibodies to B-chain determinants. Diabetes May 1980 29:383-390; doi:10.2337/diabetes.29.5.383

  2. Vassutine, I

    • Effects of intraportal islet transplantation on the transplanted tissue and the recipient pancreas. I. Functional studies. Diabetes May 1980 29:341-347; doi:10.2337/diabetes.29.5.341

W

  1. Weill, V A

    • Pirogliride: an oral hypoglycemic drug which accelerates glucose usage and insulin secretion by islets of Langerhans. Diabetes May 1980 29:410-412; doi:10.2337/diabetes.29.5.410

Y

  1. Yoshida, T

    • Effect of adrenergic agents on the secretion of gastrointestinal immunoreactive glucagon in depancreatized dogs. Diabetes May 1980 29:355-360; doi:10.2337/diabetes.29.5.355

Z

  1. Zawalich, W S

    • Pirogliride: an oral hypoglycemic drug which accelerates glucose usage and insulin secretion by islets of Langerhans. Diabetes May 1980 29:410-412; doi:10.2337/diabetes.29.5.410

Current Issue

  1. February 2012, 61 (2)
  1. Current Issue
  1. Alert me to new issues of Diabetes
Advertisement